Adria Cimino
TMFAdriaCimino
Adria Cimino is a contributing Motley Fool stock market analyst covering healthcare, technology, and consumer goods sectors. Prior to The Motley Fool, Adria covered the European stock market and U.S. stocks pre-market trading for Bloomberg News, Bloomberg TV, and Bloomberg Radio for more than a decade. Earlier in her career, she wrote about biotech, medtech, and technology companies in Boston for Mass High Tech, an American City Business Journals publication. She holds a bachelor’s degree in mass communications from the University of South Florida.
Recent Articles by Adria Cimino
Jun 19, 2025
by Adria Cimino
Got $1,000? 2 Stocks to Buy Now While They're on Sale
Jun 17, 2025
by Adria Cimino
Should You Buy Nvidia While It's Below $150?
Jun 17, 2025
by Adria Cimino
Is Nvidia Stock Your Ticket to Becoming a Millionaire?
Jun 16, 2025
by Adria Cimino
Better High-Growth AI Buy: Nvidia vs. CoreWeave
Jun 16, 2025
by Adria Cimino
My Top 5 AI Stocks to Buy Before the Second Half
Jun 13, 2025
by Adria Cimino
Is CoreWeave a Buy?
Jun 13, 2025
by Adria Cimino
Down 12%, Should You Buy the Dip on Eli Lilly?
Jun 12, 2025
by Adria Cimino
Is it Time to Dump Your Shares of Moderna?
Jun 11, 2025
by Adria Cimino
Where Will Nvidia Be in 3 Years?
Jun 10, 2025
by Adria Cimino
Is IonQ Stock a Buy Now?
Jun 9, 2025
by Adria Cimino
Could Buying Palantir Today Set You Up for Life?
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.